Peter Richardson
Chief Tech/Sci/R&D Officer bei MALLINCKRODT PLC
Profil
Peter C.
Richardson is currently the Chief Scientific Officer & Executive VP at Mallinckrodt Plc and a Member of The Royal College of Physicians.
Previously, he was the Chief Medical Officer & Executive VP-Research at Antares Pharma, Inc. from 2021 to 2022, the Chief Scientific Officer & Vice President at MannKind Corp.
from 2005 to 2012, the Senior VP & Global Head-Development Alliance at Novartis Pharmaceuticals Corp.
from 1991 to 2005, and the Senior Vice President & Head-Development at Novartis Pharma KK from 2003 to 2005.
He also served as the Chief Medical Officer at Adare Pharma Solutions, Inc. from 2016 to 2020.
Richardson received his undergraduate and doctorate degrees from The University of Nottingham.
Aktive Positionen von Peter Richardson
| Unternehmen | Position | Beginn |
|---|---|---|
| MALLINCKRODT PLC | Chief Tech/Sci/R&D Officer | 12.01.2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Peter Richardson
| Unternehmen | Position | Ende |
|---|---|---|
| ANTARES PHARMA, INC. | Chief Tech/Sci/R&D Officer | 24.05.2022 |
Adare Pharma Solutions, Inc.
 Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | President | 01.01.2016 |
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 01.01.2012 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.10.2005 |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Peter Richardson
| The University of Nottingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Health Technology |
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Health Technology |
